85 related articles for article (PubMed ID: 15603340)
21. Basis of sialic acid heterogeneity in ulcerative colitis.
Jass JR; Sugihara K; Love SB
J Clin Pathol; 1988 Apr; 41(4):388-92. PubMed ID: 3366922
[TBL] [Abstract][Full Text] [Related]
22. Surgery for neoplastic changes in ulcerative colitis--can limited resection be justified? Outcome for patients who underwent limited surgery.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
Colorectal Dis; 2006 Sep; 8(7):551-6. PubMed ID: 16919105
[TBL] [Abstract][Full Text] [Related]
23. Deletion of Mtgr1 sensitizes the colonic epithelium to dextran sodium sulfate-induced colitis.
Martinez JA; Williams CS; Amann JM; Ellis TC; Moreno-Miralles I; Washington MK; Gregoli P; Hiebert SW
Gastroenterology; 2006 Aug; 131(2):579-88. PubMed ID: 16890610
[TBL] [Abstract][Full Text] [Related]
24. Anatomic extent of colitis and disease severity are not predictors of pouchitis after restorative proctocolectomy for mucosal ulcerative colitis.
Sengul N; Wexner SD; Hui SM; Baig MK; Thomas N; Connor J; Weiss EG; Nogueras JJ; Berho M
Tech Coloproctol; 2006 Mar; 10(1):29-34; discussion 34-6. PubMed ID: 16528486
[TBL] [Abstract][Full Text] [Related]
25. [Effects of Changyanqing decoction on the expressions of interleukin-10 and intercellular adhesion molecule-1 in rats with ulcerative colitis].
Lü YH; Song WB; Xiao B; Long Y; Ji HL; Wang YY; Zhang XL; Li YF
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1891-3. PubMed ID: 18971195
[TBL] [Abstract][Full Text] [Related]
26. Decrease in binding for the neuropeptide VIP in response to marked inflammation of the mucosa in ulcerative colitis.
Jönsson M; Norrgård O; Hansson M; Forsgren S
Ann N Y Acad Sci; 2007 Jun; 1107():280-9. PubMed ID: 17804556
[TBL] [Abstract][Full Text] [Related]
27. Altered intestinal permeability is predictive of early relapse in children with steroid-responsive ulcerative colitis.
Miele E; Pascarella F; Quaglietta L; Giannetti E; Greco L; Troncone R; Staiano A
Aliment Pharmacol Ther; 2007 Apr; 25(8):933-9. PubMed ID: 17402997
[TBL] [Abstract][Full Text] [Related]
28. [Mucosal protection by phosphatidylcholine as new therapeutic concept in ulcerative colitis].
Stremmel W
Z Gastroenterol; 2013 Apr; 51(4):384-9. PubMed ID: 23585269
[TBL] [Abstract][Full Text] [Related]
29. Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients.
Rezaie A; Khalaj S; Shabihkhani M; Nikfar S; Zamani MJ; Mohammadirad A; Daryani NE; Abdollahi M
Ann N Y Acad Sci; 2007 Jan; 1095():305-14. PubMed ID: 17404043
[TBL] [Abstract][Full Text] [Related]
30. The relationship between the expression of the glucocorticoid receptor in biopsied colonic mucosa and the glucocorticoid responsiveness of ulcerative colitis patients.
Fujishima S; Takeda H; Kawata S; Yamakawa M
Clin Immunol; 2009 Nov; 133(2):208-17. PubMed ID: 19646928
[TBL] [Abstract][Full Text] [Related]
31. High-magnification chromoscopic colonoscopy in ulcerative colitis: a valid tool for in vivo optical biopsy and assessment of disease extent.
Hurlstone DP; Sanders DS; McAlindon ME; Thomson M; Cross SS
Endoscopy; 2006 Dec; 38(12):1213-7. PubMed ID: 17163321
[TBL] [Abstract][Full Text] [Related]
32. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21 expression in rectal mucosa and neoplastic development.
Mitsuhashi J; Mikami T; Saigenji K; Okayasu I
Pathol Int; 2005 Mar; 55(3):113-21. PubMed ID: 15743319
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
34. [Studies on colonic mucus release--II. Damaged colon mucosa].
Saka Y; Furukawa H; Okuma M
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Oct; 18(5):529-37. PubMed ID: 8564697
[TBL] [Abstract][Full Text] [Related]
35. Lipoxin biosynthesis in inflammatory bowel disease.
Mangino MJ; Brounts L; Harms B; Heise C
Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):84-92. PubMed ID: 16516812
[TBL] [Abstract][Full Text] [Related]
36. The intracellular potassium concentration of colonic epithelial cells in health and diffuse ulcerative colitis.
Lockwood CM; Harris J; Clark CG
Br J Surg; 1971 Apr; 58(4):295. PubMed ID: 5572330
[No Abstract] [Full Text] [Related]
37. Correlation of dendritic cell infiltration with active crypt inflammation in ulcerative colitis.
Watanabe S; Yamakawa M; Hiroaki T; Kawata S; Kimura O
Clin Immunol; 2007 Mar; 122(3):288-97. PubMed ID: 17178254
[TBL] [Abstract][Full Text] [Related]
38. Expressing the differences between Crohn disease and ulcerative colitis.
Wijmenga C
PLoS Med; 2005 Aug; 2(8):e230; quiz e304. PubMed ID: 16120009
[TBL] [Abstract][Full Text] [Related]
39. Absence of functional peroxisome proliferator-activated receptor-alpha enhanced ileum permeability during experimental colitis.
Mazzon E; Cuzzocrea S
Shock; 2007 Aug; 28(2):192-201. PubMed ID: 17515853
[TBL] [Abstract][Full Text] [Related]
40. Automated classification of inflammation in colon histological sections based on digital microscopy and advanced image analysis.
Ficsor L; Varga VS; Tagscherer A; Tulassay Z; Molnar B
Cytometry A; 2008 Mar; 73(3):230-7. PubMed ID: 18228558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
